Association of cord blood asprosin concentration with atherogenic lipid profile and anthropometric indices

• Published in: Diabetology and metabolic syndrome Vol. 14; no. 1; p. 74
• Main Authors: Hussein, Hanan Khudhair, Aubead, Nassrin Malik, Kzar, Hamzah H, Karim, Yasir Salam, Amin, Ali H, Al-Gazally, Moaed E, Ahmed, Tousief Irshad, Jawad, Mohammed Abed, Hammid, Ali Thaeer, Jalil, Abduladheem Turki, Mustafa, Yasser Fakri, Saleh, Marwan Mahmood, Heydari, Hafez
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.05.2022; BioMed Central
• Subjects: Analysis; Birth weight; Blood levels; Body measurements; Cardiovascular diseases; Comment; Cord blood; Development and progression; Diabetes; Females; Fetuses; Gestational age; Glucose; High density lipoprotein; Lipids; Low density lipoprotein; Low density lipoproteins; Metabolism; Neonates; Population studies; Pregnancy; Sensitivity analysis; Statistical analysis; Umbilical cord; Iran; Lipid profile; Umbilical cord blood; Triglyceride; Cholesterol; Asprosin
• ISSN: 1758-5996; 1758-5996
• DOI: 10.1186/s13098-022-00844-7

Elevated lipids in umbilical cord blood affect fetal programming, leading to a higher risk of developing cardiovascular disease in later life. However, the causes of changes in the lipid profile of umbilical cord blood are not clear yet. This study aimed for the first time to determine the association of asprosin concentration with TAG, TC, HDL-C, LDL-C concentrations and TAG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C/HDL-C ratio in umbilical cord blood as well as newborn anthropometric indices. This cross-sectional study was based on 450 mother- newborn pairs of a birth cohort study in Sabzevar, Iran. Multiple linear regression was used to estimate the association of lipid concentration and lipid ratios as well as birth weight (BW), birth length (BL), head circumference (HC) and chest circumference (CC) with asprosin in cord blood samples controlled for the relevant covariates. In fully adjusted models, each 1 ng/mL increase in asprosin was associated with 0.19 (95% CI 0.06, 0.31, P < 0.01), 0.19 (95% CI 0.10, 0.29, P < 0.01), 0.17 (95% CI 0.09, 0.25, P < 0.01), 0.17 (95% CI 0.09, 0.25, P < 0.01), 0.01 (95% CI 0.00, 0.013, P < 0.01), 0.01 (95% CI 0.01, 0.01, P < 0.01), 0.01 (95% CI 0.01, 0.01, P < 0.01) and 0.01 (95% CI 0.01, 0.01, P < 0.01) increase in TAG, TC, LDL-C, TAG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C/HDL-C ratio respectively. Moreover, higher asprosin levels was positively associated with newborn BW, BL, HC and CC; however, these associations were not statistically significant. Overall, our findings support the positive association between cord asprosin concentration and the development of atherogenic lipid profile in newborns. Further studies are needed to confirm the findings of this study in other populations.